Sales and Marketing

Showing 15 posts of 11526 posts found.

Four new appointments at PAN Advertising

March 15, 2012 Medical Communications, Sales and Marketing Pan Advertising

PAN Advertising has made four new appointments since Jon Linscott took over as managing director in February, with two new …

GSK chooses Infosys and Fabric Worldwide for digital platform

March 15, 2012 Medical Communications, Sales and Marketing Fabric Worldwide, GSK, Infosys, digital

GlaxoSmithKline has hired two technology companies to help it optimise digital communications in consumer healthcare and pharmaceuticals.The firm will work …
Pradaxa image

NICE recommends Pradaxa for stroke prevention

March 15, 2012 Sales and Marketing Boehringer Ingelheim, NICE, Pradaxa, atrial fibrillation

NICE has given a limited recommendation to Boehringer Ingelheim’s blood thinner Pradaxa. The watchdog said in final guidance that Pradaxa …

Dismay as Sanofi announces UK plant closure

March 15, 2012 Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing

Sanofi has decided to close down a manufacturing facility in the North East of the UK with the loss of …

Europe’s pharma sector : living through the crisis

March 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma

Pharmaceutical markets across Europe have been badly hit by the economic crisis, with revenues in some countries being decimated by …
Zytiga image

Charity attacks Scottish decision on Zytiga

March 14, 2012 Sales and Marketing Janssen, NICE, PAS, Prostate Cancer Charity, Zytiga

Scotland’s medicines regulator has turned down Janssen’s prostate cancer pill Zytiga, leading to a backlash from charities. The Scottish Medicines …
Zelboraf image

Roche’s melanoma pill launched in UK

March 14, 2012 Sales and Marketing BMS, CDF, NICE, Roche, Yervoy, Zelboraf

Roche’s Zelboraf has been launched in the UK to treat the deadliest form of skin cancer.  Zelboraf (vemurafenib) is the …
AstraZeneca picture

AstraZeneca sues FDA over generic Seroquel

March 14, 2012 Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics

AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …
Pfizer picture

Pfizer pulls out of $350 million insulin pact

March 14, 2012 Research and Development, Sales and Marketing Biocon, Humalog, Lantus, NovoLog, Pfizer

Pfizer has walked away from a research deal with India’s biggest biotech firm Biocon. Both companies were working on a …
john_brown

Dr John Brown joins BioCity Nottingham’s board

March 13, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BioCity Nottingham, BioCity Scotland, John Brown

Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …
Xarelto picture

NICE wants more information on Xarelto

March 13, 2012 Sales and Marketing Bayer, DVT, NICE, Xarelto

NICE is asking Bayer for more information about its blood thinner Xarelto in new guidance.  The watchdog is currently minded …
Zytiga image

Strong Zytiga study results could increase uptake

March 12, 2012 Research and Development, Sales and Marketing IDMC, Janssen, Provenge, Zytiga, prostate

Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …
Sanofi glucose monitor

Sanofi launches iPhone and iPod glucose monitor in the UK

March 12, 2012 Medical Communications, Sales and Marketing BGStar, Sanofi, diabetes, iPod, iphone

Sanofi has launched a new diabetes device in the UK to help patients monitor their blood sugar levels from their …
roch_d_ucb

UCB chief executive to chair IMI

March 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB

UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …
FDA picture

Prescription drugs could become OTC under FDA plans

March 12, 2012 Sales and Marketing COPD, FDA, OTC, prescribing

The FDA is considering new plans to make drugs for chronic conditions available over-the-counter. These drugs could include medicines for …
The Gateway to Local Adoption Series

Latest content